3 completed, 2 recruiting, 1 suspended, 1 unknown. 8 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 3, Recruiting 2, Suspended 1, Unknown 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Refractory Angina: new trials by email Literature Review of Refractory Angina trials Research Report on Refractory Angina
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina. XC001, Sham (No Treatment) - Refractory Angina, Coronary Artery Disease | Phase 2 | Recruiting | XyloCor Therapeutics, Inc. | 106 | 2025-07-08 | 2026-09-11 |
| Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina Bone marrow aspiration and a single intracoronary infusion of autologous bone marrow-derived mononuclear cells., Sham bone marrow aspiration and sham cell infusion (insertion of vascular access sheath). - Refractory Angina Pectoris, Refractory Angina | Phase 2 | Recruiting | Barts & The London NHS Trust | 110 | 2024-03-01 | 2026-01-07 |
| Allopurinol in Patients With Refractory Angina to Improve Ischemic Symptoms Allopurinol 300 MG, Placebo oral tablet - Refractory Angina | Phase 2 / Phase 3 | Unknown | Ministry of Health, Brazil | 40 | 2021-03-03 | 2021-02-24 |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory Angina IMB-1018972, Placebo oral tablet - Refractory Angina | Phase 2 | Withdrawn | Imbria Pharmaceuticals, Inc. | 2020-05-01 | 2025-11-10 | |
| Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA Neovasc Reducer, Control - Refractory Angina | Phase 2 | Completed | Shockwave Medical, Inc. | 104 | 2010-09-01 | 2013-11-25 |
| Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis Selected CD 133+ cells - Coronary Artery Disease, Refractory Angina | Phase 1 / Phase 2 | Completed | Pilar Jimenez Quevedo | 28 | 2008-05-01 | 2013-08-06 |
| Intramyocardial Delivery of Autologous Bone Marrow Mononuclear bone marrow derived cells - Refractory Angina | Phase 2 | Suspended | IRCCS San Raffaele | 13 | 2007-05-01 | 2012-02-02 |
| Study Protocol of Intramyocardial Injection of Autologous Bone Marrow Stem Cells for Refractory Angina Local sedation, Bone Marrow Aspiration, Minithoracotomy - Refractory Angina | Phase 2 | Completed | CellPraxis Bioengenharia Ltda. | 13 | 2005-07-01 | 2014-06-03 |
Angina Pectoris (8) · Coronary Artery Disease (3) · Myocardial Ischemia (1)
Cardiovascular Diseases (8) · Chest Pain (8) · Heart Diseases (8) · Neurologic Manifestations (8) · Pain (8) · Pathological Conditions, Signs and Symptoms (8) · Signs and Symptoms (8) · Vascular Diseases (8) · Myocardial Ischemia (7) · Arterial Occlusive Diseases (3) · Arteriosclerosis (3) · Coronary Disease (3)
Allopurinol (1) · salicylhydroxamic acid (1)
Barts & The London NHS Trust (1) · CellPraxis Bioengenharia Ltda. (1) · IRCCS San Raffaele (1) · Imbria Pharmaceuticals, Inc. (1) · Ministry of Health, Brazil (1) · Pilar Jimenez Quevedo (1) · Shockwave Medical, Inc. (1) · XyloCor Therapeutics, Inc. (1)
Brazil (2) · United Kingdom (2) · United States (2) · Belgium (1) · Canada (1) · Denmark (1) · Italy (1) · Netherlands (1) · Spain (1) · Sweden (1)
Anthony Mathur (1) · Enio Buffolo, MD, PhD (1) · Luis Henrique W Gowdak, MD, PhD (1) · Nelson A Hossne Junior, MD, PhD (1) · Paul Chamberlin, MD (1) · Pilar Jimenez-Quevedo, MD,PhD (1) · Stefan Verheye, MD (1) · Tim Henry, MD (1)
PMID 16990385, PMID 23413981, PMID 25651246, PMID 32719097, PMID 38862073
2018 (1)